Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 12/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7569293 | 0.88 | TACR1 (0.41) | TACR1CYP3A4CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL27488923 | 0.84 | TACR1 (0.42) | TACR1 | |
| SCHEMBL6042280 | 0.80 | RAB9A (0.42) | RAB9AALDH1A1GAAMAPTSMN1; SMN2 | |
| SCHEMBL6043496 | 0.79 | REN (0.50) | — | |
| SCHEMBL16291901 | 0.79 | TACR1 (0.43) | TACR1RAB9ANPC1ATMSLC6A2 | |
| SCHEMBL16291903 | 0.79 | TACR1 (0.43) | TACR1RAB9ANPC1ATMSLC6A2 | |
| SCHEMBL16291902 | 0.79 | TACR1 (0.43) | TACR1RAB9ANPC1ATMSLC6A2 | |
| SCHEMBL6041240 | 0.78 | RAB9A (0.42) | RAB9AALDH1A1GAAMAPTSMN1; SMN2 | |
| SCHEMBL7562662 | 0.77 | REN (0.48) | — | |
| SCHEMBL7562108 | 0.77 | SLC6A4 (0.39) | RAB9AALDH1A1CYP3A4CYP2D6SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002076440-A2 | METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES | ELAN PHARMACEUTICALS, INC. (US) | 2002-10-03 | — | — | WO | disclosed |